Trial Profile
Ilaris (Canakinumab) in Patient With Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis (PFAPA)
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Canakinumab (Primary)
- Indications Aphthous stomatitis; Fever; Lymphadenitis; Pharyngitis
- Focus Therapeutic Use
- 30 Aug 2018 Planned End Date changed from 1 Mar 2017 to 1 Mar 2020.
- 30 Aug 2018 Planned primary completion date changed from 1 Jan 2017 to 1 Jan 2020.
- 30 Aug 2018 Status changed from not yet recruiting to recruiting.